MedTrace Logo

ARM-ED: Advanced Respiratory Monitoring Events in Drug Toxicity

NCT05358132 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2024-06-21

No results posted yet for this study

Summary

There is a drug-related death crisis in Scotland. The majority of these deaths have involved the misuse of opiates (e.g. heroin) and benzodiazepines (e.g. valium) which cause an individual to stop breathing. The Advanced Respiratory Monitoring Events in Drug Toxicity (ARM-ED) study is a study investigating whether a wearable sensor can help detect problems with breathing in patients who have had drugs or medications that may cause this effect. The study will span a year and will study two groups of patients - those who attend with actual or expected respiratory depression secondary to acute drug toxicity and individuals who have undergone procedural sedation and analgaesia in the Emergency Department.

Conditions

  • Respiratory Insufficiency
  • Overdose of Opiate
  • Sedative Overdose
  • Sedative Toxicity

Interventions

DEVICE

Pneumowave Device placement and data capture

Participants in the acute toxicity group will be studied for a period of time during their Emergency Department attendance or in the case of PSA for the duration of their sedation and recovery period. Usual care will be provided to the patient with additional period with Pneumowave biosensor placed onto chest and data capture for a period of time whilst patient is in the Emergency Department,

Sponsors & Collaborators

  • Pneumowave Ltd

    collaborator UNKNOWN

  • NHS Greater Glasgow and Clyde

    lead OTHER

Principal Investigators

  • David J Lowe, MBChB BMSc FRCEM · NHS Greater Glasgow and Clyde

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2023-01-07
Completion
2024-03-07
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05358132 on ClinicalTrials.gov